Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results. [electronic resource] by
- Buzaid, A C
- Grimm, E A
- Ali-Osman, F
- Ring, S
- Eton, O
- Papadopoulos, N E
- Bedikian, A
- Plager, C
- Legha, S S
- Benjamin, R
Producer: 19950323
In:
Melanoma research vol. 4
Availability: No items available.
|
|
15.
|
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. [electronic resource] by
- Benjamin, R S
- Chawla, S P
- Carrasco, C H
- Raymond, A K
- Murray, J A
- Armen, T
- Patel, S
- Wallace, S
- Ayala, A
- Papadopoulos, N E
Producer: 19920811
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 3 Suppl 2
Availability: No items available.
|
|
16.
|
Osteosarcoma chemotherapy effect: a prognostic factor. [electronic resource] by
- Raymond, A K
- Chawla, S P
- Carrasco, C H
- Ayala, A G
- Fanning, C V
- Grice, B
- Armen, T
- Plager, C
- Papadopoulos, N E
- Edeiken, J
Producer: 19871203
In:
Seminars in diagnostic pathology vol. 4
Availability: No items available.
|
|
17.
|
|
|
18.
|
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma. [electronic resource] by
- Daud, A I
- Xu, C
- Hwu, W-J
- Urbas, P
- Andrews, S
- Papadopoulos, N E
- Floren, L C
- Yver, A
- Deconti, R C
- Sondak, V K
Producer: 20110411
In:
Cancer chemotherapy and pharmacology vol. 67
Availability: No items available.
|
|
19.
|
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. [electronic resource] by
- Vadhan-Raj, S
- Papadopoulos, N E
- Burgess, M A
- Linke, K A
- Patel, S R
- Hays, C
- Arcenas, A
- Plager, C
- Kudelka, A P
- Hittelman, W N
Producer: 19940512
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 12
Availability: No items available.
|
|
20.
|
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level. [electronic resource] by
- Vadhan-Raj, S
- Broxmeyer, H E
- Hittelman, W N
- Papadopoulos, N E
- Chawla, S P
- Fenoglio, C
- Cooper, S
- Buescher, E S
- Frenck, R W
- Holian, A
Producer: 19920825
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 10
Availability: No items available.
|